Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 25601 | 229 | 28.3 | 55% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | CLIN PATHOL BIOCHEM | Address | 6 | 42% | 5% | 11 |
| 2 | ALPHA2 ANTIPLASMIN | Author keyword | 4 | 23% | 7% | 16 |
| 3 | TC 99M NC100668 | Author keyword | 2 | 67% | 1% | 2 |
| 4 | ALPHA 2 ANTIPLASMIN | Author keyword | 2 | 21% | 3% | 8 |
| 5 | ALPHA 2 PLASMIN INHIBITOR | Author keyword | 2 | 33% | 2% | 4 |
| 6 | ANTIPLASMIN | Author keyword | 1 | 17% | 2% | 4 |
| 7 | PLASMIN INHIBITOR | Author keyword | 1 | 14% | 2% | 5 |
| 8 | ALPHA 2 ANTIPLASMIN PLASMIN COMPLEX | Author keyword | 1 | 50% | 0% | 1 |
| 9 | ALPHA 2 AP | Author keyword | 1 | 50% | 0% | 1 |
| 10 | ALPHA ANTIPLASMIN | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | ALPHA2 ANTIPLASMIN | 4 | 23% | 7% | 16 | Search ALPHA2+ANTIPLASMIN | Search ALPHA2+ANTIPLASMIN |
| 2 | TC 99M NC100668 | 2 | 67% | 1% | 2 | Search TC+99M+NC100668 | Search TC+99M+NC100668 |
| 3 | ALPHA 2 ANTIPLASMIN | 2 | 21% | 3% | 8 | Search ALPHA+2+ANTIPLASMIN | Search ALPHA+2+ANTIPLASMIN |
| 4 | ALPHA 2 PLASMIN INHIBITOR | 2 | 33% | 2% | 4 | Search ALPHA+2+PLASMIN+INHIBITOR | Search ALPHA+2+PLASMIN+INHIBITOR |
| 5 | ANTIPLASMIN | 1 | 17% | 2% | 4 | Search ANTIPLASMIN | Search ANTIPLASMIN |
| 6 | PLASMIN INHIBITOR | 1 | 14% | 2% | 5 | Search PLASMIN+INHIBITOR | Search PLASMIN+INHIBITOR |
| 7 | ALPHA 2 ANTIPLASMIN PLASMIN COMPLEX | 1 | 50% | 0% | 1 | Search ALPHA+2+ANTIPLASMIN+PLASMIN+COMPLEX | Search ALPHA+2+ANTIPLASMIN+PLASMIN+COMPLEX |
| 8 | ALPHA 2 AP | 1 | 50% | 0% | 1 | Search ALPHA+2+AP | Search ALPHA+2+AP |
| 9 | ALPHA ANTIPLASMIN | 1 | 50% | 0% | 1 | Search ALPHA+ANTIPLASMIN | Search ALPHA+ANTIPLASMIN |
| 10 | ALPHA2 ANTIPLASMIN PLASMIN COMPLEX | 1 | 50% | 0% | 1 | Search ALPHA2+ANTIPLASMIN+PLASMIN+COMPLEX | Search ALPHA2+ANTIPLASMIN+PLASMIN+COMPLEX |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | HUMAN ALPHA 2 PLASMIN INHIBITOR | 22 | 81% | 6% | 13 |
| 2 | ALPHA2 ANTIPLASMIN GENE | 15 | 82% | 4% | 9 |
| 3 | ALPHA 2 ANTIPLASMIN DEFICIENCY | 14 | 100% | 3% | 7 |
| 4 | HUMAN ALPHA 2 ANTIPLASMIN | 10 | 48% | 7% | 15 |
| 5 | ALPHA2 PLASMIN INHIBITOR | 9 | 43% | 7% | 17 |
| 6 | SEVERE HEMORRHAGIC TENDENCY | 8 | 100% | 2% | 5 |
| 7 | HETEROZYGOUS ALPHA 2 ANTIPLASMIN DEFICIENCY | 6 | 80% | 2% | 4 |
| 8 | ALPHA 2 PLASMIN INHIBITOR | 5 | 16% | 13% | 30 |
| 9 | ALPHA 2 ANTIPLASMIN | 5 | 18% | 10% | 24 |
| 10 | ENSCHEDE | 3 | 60% | 1% | 3 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
|---|---|---|---|---|
| Congenital alpha(2)-plasmin inhibitor deficiencies: a review | 2001 | 35 | 53 | 79% |
| Antiplasmin - The forgotten serpin? | 2005 | 28 | 29 | 59% |
| The past, present and future of plasmin inhibitor | 2005 | 12 | 65 | 66% |
| HEMOSTASIS ASSOCIATED WITH ABNORMALITIES OF FIBRINOLYSIS | 1989 | 29 | 32 | 50% |
| Clinical features and treatment of hereditary and acquired plasmin inhibitor deficiency | 1997 | 1 | 14 | 64% |
| HUMAN ALPHA(2)-PLASMIN INHIBITOR | 1993 | 5 | 25 | 68% |
| ALPHA-2 PLASMIN INHIBITOR AND ITS DEFICIENCY STATES | 1988 | 27 | 47 | 57% |
| alpha 2-antiplasmin on cardiovascular diseases | 2006 | 8 | 60 | 13% |
| INHIBITORS OF THE FIBRINOLYTIC ENZYME-SYSTEM | 1984 | 117 | 42 | 26% |
| PLATELET ALPHA-2-ANTIPLASMIN | 1989 | 0 | 10 | 40% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | CLIN PATHOL BIOCHEM | 6 | 42% | 4.8% | 11 |
| 2 | CONNECT TISSUE VASC | 1 | 50% | 0.4% | 1 |
| 3 | ORTHOPAED SURGETY | 1 | 50% | 0.4% | 1 |
| 4 | TECHNOL SEPARAT | 1 | 50% | 0.4% | 1 |
| 5 | TED R MONTOYA HEMOPHILIA PROGRAM | 0 | 33% | 0.4% | 1 |
| 6 | WILLIAM K WARREN MED | 0 | 12% | 1.3% | 3 |
| 7 | CLIN BIOCHEM KB 3011 | 0 | 20% | 0.4% | 1 |
| 8 | SECT MECH THROMBOSIS | 0 | 13% | 0.4% | 1 |
| 9 | HEMOSTASIS RHEOL THROMBOSIS | 0 | 100% | 0.4% | 1 |
| 10 | SECT HAEMOSTASIS THROMBOSIS | 0 | 100% | 0.4% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000258732 | FACTOR XIII//FACTOR XIII DEFICIENCY//MOL PATHOBIOCHEM PATHOBIOL |
| 2 | 0.0000203000 | HISTIDINE RICH GLYCOPROTEIN//HRG//HISTIDINE PROLINE RICH GLYCOPROTEIN |
| 3 | 0.0000188372 | STAPHYLOKINASE//FIBRINOLYSIS//PLASMINOGEN |
| 4 | 0.0000174536 | SECT HEPATOBILIARY SURG LIVER TRANSPLANTAT//AMINO ACIDS THERAPEUTIC USE//LIVER DISEASES COMPLICATIONS |
| 5 | 0.0000173390 | LIGNEOUS CONJUNCTIVITIS//PLASMINOGEN DEFICIENCY//HYPOPLASMINOGENEMIA |
| 6 | 0.0000125440 | PLASMINOGEN ACTIVATOR INHIBITOR 1//PAI 1//FIBRINOLYSIS |
| 7 | 0.0000116616 | PLASMINOGEN ACTIVATOR INHIBITION//PLASMIN INHIBITION//T PA ANTIGEN |
| 8 | 0.0000094988 | TAFI//CARBOXYPEPTIDASE U//THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR |
| 9 | 0.0000087188 | HEPARIN COFACTOR II//ANTITHROMBIN//ANTITHROMBIN DEFICIENCY |
| 10 | 0.0000064399 | ALLIED MED SCI SUMA KU//MED FUKUSHIMA KU//TARUMI KU |